non-drug intervention type
PreclinicalBiologic
non-drug intervention type is one of 8 biologic programs targeting Neuroendocrine Tumor. It is currently in Preclinical.
1
Indications
1
Total Trials
0
Active Trials
7
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
10 competitors in Neuroendocrine Tumor
#DrugCompanyPhaseTrials
1Lutathera
AAdvanced Accelerator Applications
Approved
Avastin
RochePhase 3
Sandostatin
Sun Pharmaceutical Industries, Inc.Phase 3
Votrient
NovartisPhase 2
Recombinant Human GM-CSF
EEastern Cooperative Oncology Group
Phase 3
Recombinant Interferon Alfa-2b
SSt. Jude Children's Research Hospital
Phase 3
Alphamedix
OOrano Med LLC
Phase 2
non-drug intervention type
UUniversity Hospital, Toulouse
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for non-drug intervention type. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Biologic[2]
- Highest Phase
- Preclinical[1]
- Company
- UUniversity Hospital, Toulouse